Get the Stockscreener App
2.38
1.71%
0.04
After Hours:
2.41
0.03
+1.26%
Anavex Life Sciences Corp stock is traded at $2.38, with a volume of 744.17K.
It is up +1.71% in the last 24 hours and down -33.15% over the past month.
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
See More
Previous Close:
$2.34
Open:
$2.35
24h Volume:
744.17K
Relative Volume:
0.82
Market Cap:
$220.62M
Revenue:
-
Net Income/Loss:
$-39.95M
P/E Ratio:
-5.1194
EPS:
-0.4649
Net Cash Flow:
$-34.08M
1W Performance:
-1.65%
1M Performance:
-33.15%
6M Performance:
-13.14%
1Y Performance:
-72.00%
1-Day Range:
$2.32
$2.43
1-Week Range:
$2.27
$2.49
52-Week Range:
$2.255
$10.38
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corp
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
2.38 | 220.62M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corp Stock (AVXL) Latest News
Anavex Life Sciences Corp. (AVXL) latest stock news and headlines - au.finance.yahoo.com
Anavex Life Sciences Corp. (AVXL) Stock Price, News, Quote & History - ca.finance.yahoo.com
Anavex Life Sciences Corp. (AVXL) stock price, news, quote and history - Yahoo Finance Singapore
Anavex Life Sciences Corp. (AVXL) Latest Stock News & Headlines - Yahoo! Finance Canada
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp.AVXL - PR Newswire
Anavex stockholders elect six directors at annual meeting - Investing.com
Anavex Life Sciences (AVXL) Board Election Confirms Shareholder Confidence Amid Valuation Challenges - GuruFocus
Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting - The Manila Times
Anavex stockholders elect six directors at annual meeting By Investing.com - Investing.com Canada
Investigation launched into Anavex Life Sciences over alleged misleading business info affecting shareholders. - Pluang
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action InvestigationAVXL - TMX Newsfile
Investigation launched into Anavex Life Sciences over alleged misleading business info to investors - Pluang
Rosen Law Firm Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action InvestigationAVXL - morning-times.com
PVG takes Anavex (NASDAQ: AVXL) proxy campaign to investors online - Stock Titan
Activist outlines 100-day overhaul plan for Anavex (AVXL) - Stock Titan
PVG Asset Management Pushes Board Changes at Anavex Life Sciences (AVXL) Ahead of Proxy Vote - GuruFocus
PVG Asset Management Announces Plan for First 100 Days at Anavex Life Sciences - The Manila Times
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring A 729.88% Potential Upside - DirectorsTalk Interviews
Anavex Life Sciences (AVXL) Faces Board Shakeup Amid Weak Valuation and Mixed Guru Interest - gurufocus.com
Glass Lewis says Anavex shareholders should vote for PVG Asset nominees - seekingalpha.com
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 17, 2026) - Stock Titan
Glass Lewis Recommends Anavex Stockholders Vote the GOLD Universal Proxy Card, Citing “Functionally Inert Stewardship” in Support of PVG Asset Management’s Call for Change - marketscreener.com
Glass Lewis Recommends Anavex Stockholders Vote the GOLD - GlobeNewswire
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 15, 2026) - Stock Titan
PVG Asset Management Believes ISS Acknowledges Anavex’s Repeated Missteps, Failed Board Oversight, Lack of Director Stock Ownership, and AVXL Stock Price Underperformance - The Manila Times
ISS backs Anavex board nominees in proxy fight - Investing.com
Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote 'FOR” All Six of Anavex’s Highly Qualified Director Nominees - The Manila Times
ISS backs Anavex board nominees in proxy fight By Investing.com - Investing.com Canada
Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial By Investing.com - Investing.com Australia
PVG Asset Management Provides Information to Shareholders of Anavex Life Sciences - marketscreener.com
Six-seat board challenge at Anavex (AVXL) heads to investor call - Stock Titan
PVG Asset Management to Host Investor Call Regarding Anavex Life Sciences Proxy Campaign - The Manila Times
CRM: Salesforce Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Anavex Life Sciences to discuss pediatric inclusion in Rett syndrome trial - Investing.com Nigeria
ANAVEX LIFE SCIENCES CORP. SEC Filing (Sep 9, 2026) - Stock Titan
Form 8K Anavex Life Sciences Corp For: 10 September By Investing.com - Investing.com Nigeria
Anavex Life Sciences Corp Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):